Vor Biopharma Inc. (VOR) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Vor Biopharma Inc. (VOR) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

VOR Cash Flow Statement

Vor Biopharma Inc. (VOR) cash flow statement — 8-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-25.67M	-38.25M	-22.8M	-53.66M	-35.18M	-31.07M	-24.06M	-23.29M	-21.85M	-30.46M	-24.03M	-27.9M	-24.1M	-24.27M	-18.35M	-18.9M	-24.99M	-22.9M	-17.59M	-17.34M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	27.03%	-23.11%	5.24%	-130.46%	-61.05%	-1.97%	-0.15%	16.54%	9.35%	-25.54%	-30.96%	-47.59%	3.57%	-5.96%	-4.32%	-8.99%	-50.87%	-29.78%	-28.99%	-110.35%
Net Income	-62.81M	-219.59M	1.72B	-812.68M	-1.57B	-32.49M	-30.71M	-27.56M	-27.84M	-30.8M	-26.26M	-33.19M	-29.98M	-28.43M	-23.91M	-23.79M	-21.66M	-22.74M	-18.25M	-18.55M
Depreciation & Amortization	36K	28K	-40K	2K	2.04M	825K	865K	820K	869K	943K	892K	-1.42M	870K	837K	632K	-419K	1.89M	426K	395K	1.13M
Stock-Based Compensation	9.4M	8.87M	8.95M	8.03M	1.84M	1.93M	1.71M	2.26M	2.79M	3.08M	1.89M	3.16M	4.24M	4.07M	3.88M	3.33M	1.74M	1.75M	1.2M	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	5.45M	0	0	0	0	0	0	0	0
Other Non-Cash Items	12.45M	187.98M	-1.76B	745.93M	1.53B	1.3M	1.26M	1.29M	922K	435K	228K	-3.16M	-67K	-63K	2.25M	2.49M	-865K	985K	893K	1.19M
Working Capital Changes	15.24M	-15.54M	3.16M	5.06M	4.63M	-2.64M	2.82M	-99K	1.41M	-4.12M	-779K	1.27M	838K	-677K	-1.2M	-518K	-6.09M	-3.32M	-1.83M	-1.11M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	8.8M	-9.1M	6.21M	5M	0	-1.37M	0	485K	551K	-2.48M	0	2.66M	0	0	1	0	0	-722K	0	1.09M
Cash from Investing	-36.53M	-263.24M	-48.97M	-244K	646K	-230K	-72K	-34K	52.99M	43.97M	10.34M	40.54M	13.64M	6.5M	-97.04M	12.7M	-2.7M	-7.05M	-5.95M	-8.49M
Capital Expenditures	-120K	-48K	-314K	-244K	-152K	-231K	-72K	-34K	-9K	-114K	-111K	-465K	-399K	-94K	-321K	-298K	-5.83M	-2.01M	-1.17M	-636K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	-799K	0	0	0	0	0	0	0	0	-41K	0	0	96.72K	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	799K	0	799K	0	0	0	0	0	0	41K	0	0	-96.72K	0	0	0	0	0
Cash from Financing	17K	74.87M	307.8M	21.55M	175.06M	-606K	53.29M	41K	-31K	96K	25K	176K	218K	2.52M	112.26M	4.08M	604K	200K	307K	201K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	123K	74.87M	307.93M	21.57M	175.1M	-551K	55.53M	111K	20K	278K	-15K	392K	579K	3.62M	111.63M	3.84M	504K	200K	-1K	201K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-4K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	-106K	-2K	-131K	-19K	-32K	-55K	-2.24M	-70K	-51K	-182K	40K	-216K	-361K	-1.1M	631K	234K	100K	0	308K	0
Net Change in Cash	-62.19M	-226.61M	236.19M	-32.52M	140.53M	-31.9M	29.15M	-23.28M	31.11M	13.6M	-13.67M	12.81M	-10.24M	-15.25M	-3.12M	-2.13M	-27.09M	-29.76M	-23.23M	-26.48M
Free Cash Flow	-25.79M	-38.29M	-23.11M	-53.91M	-35.34M	-31.3M	-24.14M	-23.32M	-21.86M	-30.58M	-24.14M	-28.36M	-24.5M	-24.36M	-18.67M	-19.2M	-30.82M	-24.91M	-18.75M	-17.98M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	27%	-22.36%	4.23%	-131.17%	-61.68%	-2.35%	0.01%	17.78%	10.79%	-25.52%	-29.3%	-47.72%	20.52%	2.22%	0.47%	-6.79%	-76.3%	-32.39%	-24.11%	-82.86%
FCF per Share	-0.47	-89.03	-2.34	-8.07	-5.64	-5.01	-7.03	-6.81	-6.40	-8.99	-7.11	-8.39	-7.31	-7.35	-8.03	-10.10	-16.47	-13.36	-10.16	-9.74
FCF Conversion (FCF/Net Income)	0.41x	0.17x	-0.01x	0.07x	0.02x	0.96x	0.78x	0.84x	0.78x	0.99x	0.91x	0.84x	0.80x	0.85x	0.77x	0.79x	1.15x	1.01x	0.96x	0.93x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0